Related Experiment Video

Updated: Aug 16, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Respiratory syncytial virus-related bronchiolitis in Puerto Rico

María Molinari Such1, Inés García, Lourdes García

  • 1Department of Pediatrics, Neonatology Section, Medical Sciences Campus, University of Puerto Rico, the San Jorge Childrens Hospital, San Juan, PR.

Puerto Rico Health Sciences Journal
|August 25, 2005
PubMed

Insights

Respiratory syncytial virus (RSV) infections occur year-round in Puerto Rico, with a notable decrease possibly linked to immunoprophylaxis. A robust surveillance system is crucial for understanding RSV epidemiology.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • Respiratory syncytial virus (RSV) is a significant pathogen causing respiratory illness in young children.
  • Immunoprophylaxis is an available preventive measure for high-risk infants.
  • This study investigates the epidemiology of RSV in Puerto Rico.

Purpose of the Study:

  • To describe the epidemiology of RSV infection in infants with bronchiolitis in Puerto Rico.
  • To analyze RSV incidence across three primary care hospitals.

Main Methods:

  • Retrospective analysis of infant bronchiolitis cases from three hospitals.
  • Estimation of RSV-attributable percentage of cases in two hospitals.
  • Inclusion of confirmed RSV infection data from a third hospital.

Main Results:

  • A total of 4,557 patients were included in the study.
  • RSV infections were observed throughout the year.
  • A decreasing trend in RSV-positive infections was identified.

Conclusions:

  • RSV demonstrates year-round incidence in Puerto Rico.
  • A standardized surveillance system is essential for accurate RSV epidemiology.
  • The observed decline in RSV infections may be attributed to the implementation of immunoprophylaxis for high-risk infants.
Abstract

More Related Videos

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...